Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Director/PDMR Shareholding

29 Oct 2014 13:36

RNS Number : 6140V
Ricardo PLC
29 October 2014
 



Ricardo PLC

 

Director / PDMR Shareholdings

 

29 October 2014

London

 

1. 2014 Long Term Incentive Plan - grant of plan cycle 8

 

Ricardo PLC (the "Company") announces that, on 29 October 2014, conditional awards over a total of 180,227 shares of 25 pence each in the Company ("Shares") were granted to Executive Directors and other PDMRs as set out below under the terms of the Company's 2014 Long Term Incentive Plan (the "LTIP") which was approved by shareholders at today's Annual General Meeting. These awards vest after three years and are subject to TSR and EPS performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

69,269

Ian Gibson

Executive Director

24,525

Mark Garrett

Executive Director

21,404

Clive Wotton

PDMR

7,931

Robert Hentschel

PDMR

7,617

Markus Döerr

PDMR

11,542

Gary Tan

PDMR

8,601

Robert Bell

PDMR

8,611

Martin Fausset

PDMR

13,620

Mark Barge

PDMR

7,107

 

2. 2011 Deferred Bonus Plan - grant of deferred awards and matching awards

 

The Company also announces that, on 29 October 2014, conditional "deferred awards" over a total of 35,691 Shares were granted to Executive Directors and other PDMRs under the terms of the Company's 2011 Deferred Bonus Plan ("DBP"), as set out below. Subject to continuing employment, the awards granted to Executive Directors vest after three years and the awards granted to other PDMRs (with the exception of Mark Barge whose award vests on the first anniversary of grant) vest in equal tranches on the first, second and third anniversaries of grant. These DBP deferred awards (which include dividend equivalent entitlements) are not subject to performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

16,640

Ian Gibson

Executive Director

8,082

Mark Garrett

Executive Director

6,859

Clive Wotton

PDMR

680

Gary Tan

PDMR

1,331

Mark Barge

PDMR

2,099

 

Finally, further conditional "matching awards" over a total of 31,581 Shares were granted to Executive Directors under the terms of the DBP on the basis of one Share comprised in such a "matching award" for each Share comprised in the corresponding deferred award (detailed above) granted to an individual on the same occasion. Details of these DBP matching awards, which only include dividend equivalent entitlements in limited circumstances, but are subject to the same performance conditions that apply to the awards granted on 29 October 2014 under cycle 8 of the LTIP, are set out below:

 

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

16,640

Ian Gibson

Executive Director

8,082

Mark Garrett

Executive Director

6,859

 

 

3. Current total holdings of awards / options over Shares

 

Following the above notifications, the total number of Shares over which the relevant Executive Directors and other PDMRs hold outstanding awards / options is set out below:

 

 Name

Role

Total no. of Shares subject to awards and options now held

Approximate % of Company's issued share capital

Dave Shemmans

Executive Director

590,782

1.13%

Ian Gibson

Executive Director

66,672

0.13%

Mark Garrett

Executive Director

205,848

0.39%

Clive Wotton

PDMR

20,127

0.04%

Robert Hentschel

PDMR

16,232

0.03%

Markus Döerr

PDMR

84,407

0.16%

Gary Tan

PDMR

39,033

0.07%

Robert Bell

PDMR

32,165

0.06%

Martin Fausset

PDMR

76,096

0.15%

Mark Barge

PDMR

19,372

0.04%

 

The above notifications are intended to satisfy the Company's obligations under Disclosure and Transparency Rule ("DTR") 3.1.4R.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMMZGFLDGDZM
Date   Source Headline
2nd Jan 20254:37 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSRicardo completes sale of Ricardo Defense
19th Dec 202411:49 amRNSHolding(s) in Company
18th Dec 202410:48 amRNSDirector/PDMR Shareholding
17th Dec 20243:40 pmRNSDirector/PDMR Shareholding
17th Dec 20243:39 pmRNSHolding(s) in Company
16th Dec 20247:01 amRNSRicardo to acquire E3 Advisory
16th Dec 20247:00 amRNSRicardo divests Ricardo Defense
11th Dec 20242:13 pmRNSHolding(s) in Company
2nd Dec 20245:01 pmRNSHolding(s) in Company
2nd Dec 202411:41 amRNSDirector/PDMR Shareholding
22nd Nov 20241:01 pmRNSDirector/PDMR Shareholding
22nd Nov 202412:51 pmRNSHolding(s) in Company
18th Nov 20243:31 pmRNSDirector/PDMR Shareholding
18th Nov 20242:02 pmRNSHolding(s) in Company - replacement
18th Nov 202412:46 pmRNSDirector/PDMR Shareholding
15th Nov 20244:20 pmRNSResult of AGM
30th Oct 202410:28 amRNSDirector/PDMR Shareholding
28th Oct 20245:29 pmRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSStrategy Update
17th Oct 20248:54 amRNSDirectorate Change
14th Oct 20242:12 pmRNSDirector/PDMR Shareholding
8th Oct 20245:39 pmRNSDirector/PDMR Shareholding
30th Sep 202411:15 amRNSTransaction in Own Shares
17th Sep 202411:04 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSPreliminary Results
3rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
28th Aug 202412:00 pmRNSDirectorate Change
21st Aug 202410:52 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTrading Update
15th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 202410:50 amRNSDirectorate Change
12th Jun 20249:30 amRNSDirector/PDMR Shareholding
15th May 20243:20 pmRNSDirector/PDMR Shareholding
13th May 20249:25 amRNSDirector/PDMR Shareholding
3rd May 20247:43 amRNSDirectorate Change
30th Apr 20243:40 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:14 amRNSDirector/PDMR Shareholding
22nd Apr 202411:08 amRNSHolding(s) in Company
11th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20241:48 pmRNSHolding(s) in Company
15th Mar 20245:30 pmRNSHolding(s) in Company
12th Mar 20245:30 pmRNSDirector/PDMR Shareholding
8th Mar 202410:30 amRNSInvestor Meet Company Webinar
7th Mar 20243:26 pmRNSDirector/PDMR Shareholding
7th Mar 202411:55 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSInterim Results
5th Mar 202410:04 amRNSDirectorate Change
13th Feb 20249:39 amRNSDirector/PDMR Shareholding
6th Feb 202410:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.